TrialJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2025

Lazertinib for Patients with NSCLC Harboring Uncommon EGFR Mutations: A Phase II Multicenter Trial.

Sehhoon Park et al.PubMed ↗Publisher ↗

No numbers read from the abstract.